logo

For the Inventor, By the Inventor

Hovas, Sweden

Hans-Arne Hansson

This inventor holds 10 USPTO granted patents. Top assignees: Lantmannen As-Faktor Ab, Institute of Molecular Biology, Inc., As Faktor Ab. Active years: 1997-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Arne Hansson. Retrieved from https://idiyas.com/inventor/hans-arne-hansson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 70.0

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 65(Granted Patents)


Location History:

  • Hovås, SE (2013 - 2014)
  • Hovás, SE (2012 - 2015)
  • Hovas, SE (1997 - 2018)

Company Filing History:

goldMedal6 out of 8 
 
Lantmannen As-Faktor Ab
 patents
silverMedal2 out of 9 
 
Institute of Molecular Biology, Inc.
 patents
bronzeMedal1 out of 1 
 
As Faktor Ab
 patent
4. 1 out of 834,513 
Other
 patents

Years Active: 1997-2018

Loading Chart...
10 patents (USPTO):Explore Patents
1. 9962424 - Use of antisecretory factors (AF) for optimizing cellular uptake (2018-05-08),
2. 9220750 - Use of antisecretory factors (AF) for optimizing cellular uptake (2015-12-29),
3. 9000125 - Approach to treat intraocular hypertension (2015-04-07),
4. 8748367 - Use of antisecretory factor (2014-06-10),
5. 8487074 - Modulation of lipid rafts (2013-07-16),
6. 8389468 - Approach to the treatment of compartment syndrome (2013-03-05),
7. 8309513 - Approach to the treatment of compartment syndrome (2012-11-13),
8. 8207296 - Approach to treat intraocular hypertension (2012-06-26),
9. 6506727 - Nerve regeneration (2003-01-14),
10. 5656605 - Device to promote drug-induced nerve regeneration (1997-08-12),

Title: The Innovations of Hans-Arne Hansson

Introduction

Hans-Arne Hansson is a notable inventor based in Hovás, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in optimizing cellular uptake of various substances. With a total of 10 patents to his name, Hansson's work has the potential to impact medical treatments significantly.

Latest Patents

One of Hansson's latest patents focuses on the use of antisecretory factors (AF) for optimizing cellular uptake. This invention relates to the application of an AF protein, peptide, derivative, homologue, and/or fragment that possesses equivalent functional activity. The patent emphasizes the importance of these factors in enhancing the delivery and cellular uptake of pharmaceutical substances or formulations. These substances may include anticancer drugs, radiation therapy, antibiotics, antiviral agents, and drugs targeting various medical conditions such as posttraumatic injuries and neurodegeneration.

Career Highlights

Throughout his career, Hans-Arne Hansson has worked with reputable organizations, including Lantmännen As-faktor AB and the Institute of Molecular Biology, Inc. His experience in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical science.

Collaborations

Hansson has collaborated with several professionals in his field, including Stefan Lange and Eva Jennische. These partnerships have likely facilitated the exchange of ideas and fostered innovation in his research endeavors.

Conclusion

Hans-Arne Hansson's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work in optimizing cellular uptake has the potential to enhance medical treatments and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…